PL2964215T3 - Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych - Google Patents

Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych

Info

Publication number: PL2964215T3
Authority: PL; Poland
Prior art keywords: mixture; treatment; fatty acids; inflammatory pathologies; pathologies
Prior art date: 2013-03-08

Application number

PL14708015T

Other languages

English (en)

Inventor

Lodovico BURATTIN

Original Assignee

Again Life Italia Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-08

Filing date

2014-03-04

Publication date

2020-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2964215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-04 Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl

2020-03-31 Publication of PL2964215T3 publication Critical patent/PL2964215T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fats And Perfumes (AREA)

PL14708015T 2013-03-08 2014-03-04 Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych PL2964215T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201361774796P	2013-03-08	2013-03-08
IT000354A ITMI20130354A1 (it)	2013-03-08	2013-03-08	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
PCT/EP2014/054163 WO2014135529A1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids for use in the treatment of inflammatory pathologies
EP14708015.4A EP2964215B1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (1)

Publication Number	Publication Date
PL2964215T3 true PL2964215T3 (pl)	2020-03-31

Family

ID=48227394

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL17169929T PL3219316T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych
PL14708015T PL2964215T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL17169929T PL3219316T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych

Country Status (18)

Country	Link
US (2)	US11020365B2 (pl)
EP (2)	EP2964215B1 (pl)
AU (2)	AU2014224710B2 (pl)
CA (1)	CA2904112C (pl)
CY (2)	CY1122248T1 (pl)
DK (2)	DK3219316T3 (pl)
EA (2)	EA036724B1 (pl)
ES (2)	ES2753257T3 (pl)
HK (1)	HK1243924A1 (pl)
HR (2)	HRP20191963T1 (pl)
HU (2)	HUE048361T2 (pl)
IT (1)	ITMI20130354A1 (pl)
LT (2)	LT2964215T (pl)
PL (2)	PL3219316T3 (pl)
PT (2)	PT2964215T (pl)
RS (2)	RS59523B1 (pl)
SI (2)	SI2964215T1 (pl)
WO (1)	WO2014135529A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20130354A1 (it)	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
JP7118642B2 (ja) *	2014-08-08	2022-08-16	アリリサーチソシエタアレスポンサビリタリミタータセンプリフィカタ	炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
AR102008A1 (es) *	2015-09-24	2017-01-25	Brix S R L	Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
CN112469406B (zh) *	2018-05-31	2024-05-17	财团法人峨山社会福祉财团	硬脂酸用于预防或治疗肺纤维化的用途
KR102204097B1 (ko) *	2019-01-31	2021-01-18	동신대학교 산학협력단	지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
JP2023513759A (ja) *	2020-02-12	2023-04-03	レトロトップ、インコーポレイテッド	化粧品用途のための重水素化多価不飽和脂肪酸またはそのエステル
AU2022328181A1 (en) *	2021-08-09	2024-03-21	Kentucky Equine Research, Inc.	Compositions and methods for modulating equine fatty acid profiles
AU2022396538A1 (en) *	2021-11-24	2024-03-21	Jenivision Inc.	Delivery methods for treating brain and central nervous system diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY24246A1 (es)	1995-06-06	1996-06-14	Neutrogena Corp	Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
GB9923738D0 (en)	1999-10-07	1999-12-08	Nestle Sa	Nutritional composition
DE10161729A1 (de)	2001-12-15	2003-06-18	Mira Ursic	Medizinische bzw. pharmazeutische Salbenzubereitung
DE50211883D1 (de)	2002-04-30	2008-04-24	Cognis Ip Man Gmbh	Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US7612111B2 (en) *	2003-03-20	2009-11-03	Imagenetix, Inc.	Esterified fatty acid composition
US20080057552A1 (en) *	2006-08-31	2008-03-06	Inmok Lee	Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en)	2006-12-20	2009-07-31	Seperex Nutritionals Ltd	An extract
JP4512881B2 (ja) *	2007-11-27	2010-07-28	築中島	薬用油脂
US8765661B2 (en) *	2008-03-20	2014-07-01	Virun, Inc.	Compositions containing non-polar compounds
US20090264520A1 (en)	2008-04-21	2009-10-22	Asha Lipid Sciences, Inc.	Lipid-containing compositions and methods of use thereof
DK2349250T3 (en) *	2008-10-31	2017-07-03	Lipid Pharmaceuticals Ehf	Fatty acids for use as a medicament
US9062275B2 (en)	2009-04-17	2015-06-23	Natac Pharma, S.L.	Compositions rich in omega-3 fatty acids with a low content in phytanic acid
PL2475352T5 (pl)	2009-09-07	2019-02-28	Epitech Group S.P.A.	Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji
CA2703532C (en)	2010-05-10	2018-05-01	Eva Turley	Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de)	2010-05-27	2011-12-01	Intendis Gmbh	Azelainsäurehaltige Formulierung mit Pigmentzusatz
RS61153B1 (sr)	2011-01-07	2020-12-31	Anji Pharma Us Llc	Ligand hemosenzornog receptora-osnovne terapije
US20120252888A1 (en) *	2011-03-29	2012-10-04	Palupa Medical Ltd.	Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it)	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

2013
- 2013-03-08 IT IT000354A patent/ITMI20130354A1/it unknown
2014
- 2014-03-04 RS RS20191396A patent/RS59523B1/sr unknown
- 2014-03-04 EP EP14708015.4A patent/EP2964215B1/en active Active
- 2014-03-04 SI SI201431377T patent/SI2964215T1/sl unknown
- 2014-03-04 PL PL17169929T patent/PL3219316T3/pl unknown
- 2014-03-04 EP EP17169929.1A patent/EP3219316B1/en active Active
- 2014-03-04 PT PT147080154T patent/PT2964215T/pt unknown
- 2014-03-04 US US14/772,768 patent/US11020365B2/en active Active
- 2014-03-04 EA EA201791885A patent/EA036724B1/ru unknown
- 2014-03-04 DK DK17169929.1T patent/DK3219316T3/da active
- 2014-03-04 HU HUE17169929A patent/HUE048361T2/hu unknown
- 2014-03-04 CA CA2904112A patent/CA2904112C/en active Active
- 2014-03-04 ES ES14708015T patent/ES2753257T3/es active Active
- 2014-03-04 DK DK14708015T patent/DK2964215T3/da active
- 2014-03-04 WO PCT/EP2014/054163 patent/WO2014135529A1/en active Application Filing
- 2014-03-04 PL PL14708015T patent/PL2964215T3/pl unknown
- 2014-03-04 LT LT14708015T patent/LT2964215T/lt unknown
- 2014-03-04 RS RS20200252A patent/RS60023B1/sr unknown
- 2014-03-04 PT PT171699291T patent/PT3219316T/pt unknown
- 2014-03-04 HU HUE14708015A patent/HUE046239T2/hu unknown
- 2014-03-04 LT LTEP17169929.1T patent/LT3219316T/lt unknown
- 2014-03-04 AU AU2014224710A patent/AU2014224710B2/en active Active
- 2014-03-04 ES ES17169929T patent/ES2779851T3/es active Active
- 2014-03-04 SI SI201431512T patent/SI3219316T1/sl unknown
- 2014-03-04 EA EA201591680A patent/EA035091B1/ru unknown
2018
- 2018-03-12 HK HK18103386.6A patent/HK1243924A1/zh unknown
- 2018-03-27 AU AU2018202190A patent/AU2018202190B2/en active Active
2019
- 2019-10-30 HR HRP20191963TT patent/HRP20191963T1/hr unknown
- 2019-11-05 CY CY20191101148T patent/CY1122248T1/el unknown
2020
- 2020-03-10 HR HRP20200394TT patent/HRP20200394T1/hr unknown
- 2020-03-16 CY CY20201100229T patent/CY1122783T1/el unknown
2021
- 2021-04-29 US US17/244,036 patent/US20210290578A1/en active Pending

Also Published As

Publication number	Publication date
AU2018202190B2 (en)	2019-05-02
EA201791885A1 (ru)	2018-01-31
PL3219316T3 (pl)	2020-06-01
RS59523B1 (sr)	2019-12-31
AU2018202190A1 (en)	2018-04-26
ES2753257T3 (es)	2020-04-07
HUE046239T2 (hu)	2020-02-28
WO2014135529A1 (en)	2014-09-12
RS60023B1 (sr)	2020-04-30
US20160015666A1 (en)	2016-01-21
ITMI20130354A1 (it)	2014-09-09
LT3219316T (lt)	2020-04-10
SI2964215T1 (sl)	2019-12-31
HUE048361T2 (hu)	2020-08-28
EP2964215A1 (en)	2016-01-13
EP3219316A1 (en)	2017-09-20
CY1122783T1 (el)	2021-05-05
US20210290578A1 (en)	2021-09-23
DK3219316T3 (da)	2020-03-16
CA2904112C (en)	2021-03-23
EP3219316B1 (en)	2020-02-19
AU2014224710B2 (en)	2018-04-12
HRP20191963T1 (hr)	2020-01-24
EP2964215B1 (en)	2019-08-21
US11020365B2 (en)	2021-06-01
HK1243924A1 (zh)	2018-07-27
CY1122248T1 (el)	2020-11-25
EA035091B1 (ru)	2020-04-27
PT2964215T (pt)	2019-11-12
EA036724B1 (ru)	2020-12-11
HRP20200394T1 (hr)	2020-06-12
PT3219316T (pt)	2020-03-27
CA2904112A1 (en)	2014-09-12
EA201591680A1 (ru)	2015-12-30
LT2964215T (lt)	2019-11-25
DK2964215T3 (da)	2019-11-11
SI3219316T1 (sl)	2020-07-31
ES2779851T3 (es)	2020-08-20
AU2014224710A1 (en)	2015-09-10

Publication	Publication Date	Title
SG10201800243XA (en)	2018-02-27	SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
PL3020401T3 (pl)	2020-05-18	Pemafibrat do stosowania w leczeniu niealkoholowej stłuszczeniowej choroby wątroby
LT2964215T (lt)	2019-11-25	Riebalų rūgščių mišinys, skirtas naudoti uždegiminių patologijų gydymui
EP2941252A4 (en)	2016-07-13	USE OF FATTY ACID NIACIN CONJUGATES FOR THE TREATMENT OF DISEASES
IL250271B (en)	2022-10-01	A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
ZA201604225B (en)	2017-08-30	Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
HRP20181913T1 (hr)	2019-01-11	Sastav za liječenje upale bolesti zglobova
EP2968246A4 (en)	2016-08-03	OMEGA 3 PENTANOIC ACID COMPOSITIONS AND METHODS OF USE
GB201406396D0 (en)	2014-05-21	The treatment of inflammatory disorders
IL245199A (en)	2017-02-28	Processes for making unsaturated esters
IL242711B (en)	2019-05-30	Agomelatine formulations comprising agomelatine in the form of co-crystals
PL3079684T3 (pl)	2020-06-01	Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
SG11201601297YA (en)	2016-03-30	Supported composition and the use thereof in methods for the hydroformylation of unsaturated compounds
GB201208974D0 (en)	2012-07-04	Improvements in the manufacture of fatty acids
GB201104653D0 (en)	2011-05-04	Improvements in the manufacture of fatty acids